The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coronary intervention

American Journal of Medicine

Volumn 124, Issue 3, 2011, Pages 265-275

  Lingman, Markus ^a,c   Albertsson, Per ^a   Herlitz, Johan ^a   Bergfeldt, Lennart ^a   Lagerqvist, Bo ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c HALMSTAD HOSPITAL   (Sweden)

Author keywords

Diabetes; Hypertension; Percutaneous coronary intervention; Prognosis

Indexed keywords

ABCIXIMAB; ACARBOSE; ACETYLSALICYLIC ACID; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; EPTIFIBATIDE; FONDAPARINUX; GLIBENCLAMIDE; HEPARIN; HIRULOG; INSULIN; LOOP DIURETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; METFORMIN; POTASSIUM SPARING DIURETIC AGENT; SITAGLIPTIN; THIAZIDE DIURETIC AGENT; TICLOPIDINE; VILDAGLIPTIN; WARFARIN;

AGED; ALLERGIC REACTION; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION; HEART TAMPONADE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REPEAT PROCEDURE; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SWEDEN; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; REGISTRIES; RETREATMENT; STROKE; SWEDEN; TREATMENT OUTCOME;

EID: 79952480387     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.09.015     Document Type: Article

References (40)

1. S.R. Wilson, B.A. Vakili, and W. Sherman Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention Diabetes Care 27 2004 1137 1142 (Pubitemid 38579779)
2. S.P. Marso, T. Miller, and B.D. Rutherford Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial) Am J Cardiol 100 2007 206 210 (Pubitemid 47041980)
3. V. Mathew, B.J. Gersh, and B.A. Williams Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial Circulation 109 2004 476 480 (Pubitemid 38168509)
4. B. Upadhya, D.C. Sane, and R.J. Appelgate Differences in baseline characteristics and in-hospital outcomes in patients with or without prior stroke undergoing percutaneous coronary intervention J Invasive Cardiol 17 2005 243 247 (Pubitemid 40632188)
5. L. Gruberg, N.J. Weissman, and R. Waksman The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox J Am Coll Cardiol 39 2002 578 584 (Pubitemid 34158151)
6. E. Nikolsky, G. Stone, and C.L. Grines Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction Am Heart J 151 2006 168 175 (Pubitemid 41815349)
7. H. Mehrdad Sadeghi, G.W. Stone, and C.L. Grines Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction Circulation 108 2003 2769 2775 (Pubitemid 37498979)
8. S. Vasu, L. Gruberg, and D.L. Brown The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction Catheter Cardiovasc Interv 70 2007 701 705 (Pubitemid 350144451)
9. D. Inaguma, M. Tatematsu, and H. Shinjo Relationship between renal function at the time of percutaneous coronary intervention and prognosis in ischemic heart disease patients Clin Exp Nephrol 11 2007 56 60 (Pubitemid 46474956)
10. K. Sakai, Y. Nakagawa, and Y. Soga Comparison of 30-day outcomes in patients <75 years of age versus <75 years of age with acute myocardial infarction treated by primary coronary angioplasty Am J Cardiol 98 2006 1018 1021 (Pubitemid 44486140)
11. E. Argulian, A.D. Patel, and J.L. Abramson Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions J Cardiol 98 2006 48 53 (Pubitemid 43902676)
12. J.S. Berger, T.A. Sandborn, W. Sherman, and D.L. Brown Influence of sex on in-hospital outcomes and long term survival after contemporary percutaneous coronary intervention Am Heart J 151 2006 1026 1031
13. R. Glaser, F. Selzer, and A.K. Jacobs Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes Am J Cardiol 98 2006 1446 1450 (Pubitemid 44779470)
14. T.Z. Naqvi, S. Padmanabhan, and F. Rafii Comparison of usefulness of left ventricular diastolic versus systolic function as a predictor of outcome following primary percutaneous coronary angioplasty for acute myocardial infarction Am J Cardiol 97 2006 160 166 (Pubitemid 43139228)
15. E.M. Holper, J. Blair, F. Selzer Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry Investigators The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry Am Heart J 151 2006 69 75 (Pubitemid 41815333)
16. K. Wolf-Maier, R.S. Cooper, and J.R. Banegas Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States JAMA 289 2003 2363 2369 (Pubitemid 37430168)
17. A. Breeman, M. Hordijk-Trion, and M. Lenzen Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization J Thorac Cardiovasc Surg 132 2006 1001 1009 (Pubitemid 44584946)
18. D.O. Williams, J.D. Abbot, and K.E. Kip Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry Circulation 114 2006 2154 2162 (Pubitemid 44747896)
19. B.M. Psaty, C.D. Furberg, and L.H. Kuller Association between blood pressure level and the risk of myocardial infarction, stroke and total mortality: The Cardiovascular Health Study Arch Intern Med 161 2001 1183 1192 (Pubitemid 32691515)
20. P.W. Wilson An epidemiologic perspective of systemic hypertension, ischemic heart disease, and heart failure (The Framingham Heart Study) Am J Cardiol 80 1997 3 8
21. R.B. Devereux, G. de Simeone, A. Ganau, and M.J. Roman Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications J Hypertens Suppl 12 1994 S117 S127
22. D. Levy, R.J. Garrison, and D.D. Savage Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 22 1990 1561 1566 (Pubitemid 20176696)
23. P. Verdecchia, G. Schillaci, and C. Borgioni Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy J Am Coll Cardiol 31 1998 383 390 (Pubitemid 28153459)
24. D. Levy, M. Salomon, and R.B. D'Agostino Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy Circulation 90 1994 1786 1793 (Pubitemid 24320926)
25. J. Mathew, P. Sleight, and E. Lonn Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril Circulation 104 2001 1615 1621 (Pubitemid 32947523)
26. E.P. Havranek, A. Esler, and R.O. Estacio Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial Am Heart J 145 2003 993 998 (Pubitemid 36688249)
27. P.M. Okin, R.B. Devereux, and S. Jern Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and prediction of major cardiovascular events JAMA 292 2004 2343 2349 (Pubitemid 39491918)
28. V. Palmieri, J.N. Bella, and D.R. Arnett Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study Circulation 103 2001 102 107 (Pubitemid 32050443)
29. J.N. Bella, R.B. Devereux, and M.J. Roman Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study) Am J Cardiol 87 2001 1260 1265 (Pubitemid 32493866)
30. A. Rubulis, J. Jensen, and G. Lundahl Ischemia induces aggravation of baseline repolarization abnormalities in left ventricular hypertrophy: a deleterious interaction J Appl Physiol 101 2006 102 110 (Pubitemid 44035354)
31. S. Verma, P.W. Fedak, and R.D. Wiesel Fundamentals of reperfusion injury for the clinical cardiologist Circulation 105 2002 2332 2336 (Pubitemid 34556381)
32. D.N. Granger Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease Microcirculation 6 1999 167 178 (Pubitemid 129671256)
33. R.J. Myerburg, A. Castellanos, and H.V. Huikuri Origins, classification and significance of ventricular arrhythmias P.M. Spooner, M.R. Rosen, Foundations of Cardiac Arrhythmias: Basic Concepts and Clinical Approaches 2001 Dekker New York 547 569
34. A.W. Haider, M.G. Larson, E.J. Benjamin, and D. Levy Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death J Am Coll Cardiol 32 1998 1454 1459 (Pubitemid 28522409)
35. M. Lingman, J. Herlitz, and L. Bergfeldt Acute coronary syndromes: the prognostic impact of hypertension, diabetes and its combination on long-term outcome Int J Cardiol 137 2009 29 36
36. T. Kasai, K. Miyauchi, and T. Kurata Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention Hypertens Res 31 2008 235 241 (Pubitemid 351461102)
37. L. Zhou, W. Deng, and L. Zhou Prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population: systematic review Curr Diabetes Rev 5 2009 171 184
38. D. Erlinge, C. Varenhorst, and O. Braun Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo J Am Coll Cardiol 52 2008 1968 1977
39. S.D. Wiviott, E. Braunwald, and D.J. Angiolillo Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38 Circulation 118 2008 1626 1636
40. R. Mehta, A. Starr, and R. Lopes Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention JAMA 301 2009 1779 1789